| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1991PNAS...8810850A |
| P356 | DOI | 10.1073/PNAS.88.23.10850 |
| P932 | PMC publication ID | 53029 |
| P698 | PubMed publication ID | 1961755 |
| P5875 | ResearchGate publication ID | 21193761 |
| P50 | author | John Q. Trojanowski | Q6253636 |
| P2093 | author name string | Gur RE | |
| Lee VM | |||
| Arnold SE | |||
| P2860 | cites work | Alzheimer disease tangles share immunological similarities with multiphosphorylation repeats in the two large neurofilament proteins | Q33652987 |
| Differential expression of distinct microtubule-associated proteins during brain development | Q37532058 | ||
| The basis of polarity in neurons | Q38204817 | ||
| Efferents and afferents of the ventral tegmental-A10 region studied after local injection of [3H]leucine and horseradish peroxidase | Q39571863 | ||
| Microtubule-associated proteins: their potential role in determining neuronal morphology | Q39639380 | ||
| Limbic pathology in schizophrenia: the entorhinal region--a morphometric study. | Q41395921 | ||
| Cell loss in the hippocampus of schizophrenics | Q41478815 | ||
| Distribution of tau proteins in the normal human central and peripheral nervous system | Q44921131 | ||
| Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder | Q45297275 | ||
| Hippocampal pyramidal cell orientation in schizophrenia. A controlled neurohistologic study of the Yakovlev collection | Q48173287 | ||
| Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats | Q48190050 | ||
| Microtubule-associated proteins and the stimulation of tubulin assembly in vitro | Q48357942 | ||
| Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics | Q48391174 | ||
| Differential localization of MAP-2 and tau in mammalian neurons in situ | Q48412407 | ||
| A neurohistological correlate of schizophrenia | Q48593474 | ||
| Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia | Q48691523 | ||
| Phylogenetic conservation of brain microtubule-associated proteins MAP2 and tau. | Q52250462 | ||
| Two-stage expression of neurofilament polypeptides during rat neurogenesis with early establishment of adult phosphorylation patterns. | Q52254855 | ||
| Hippocampal pathologic findings in schizophrenia. A morphometric study. | Q52515251 | ||
| Organization of microtubules in dendrites and axons is determined by a short hydrophobic zipper in microtubule-associated proteins MAP2 and tau | Q59067304 | ||
| Neuronal microtubule-associated proteins in the embryonic avian spinal cord | Q68415312 | ||
| Experimentally induced visual projections into auditory thalamus and cortex | Q69048769 | ||
| Distribution of phosphate-independent MAP2 epitopes revealed with monoclonal antibodies in microwave-denatured human nervous system tissues | Q69096081 | ||
| An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients | Q69112689 | ||
| Prenatal developmental disturbances in the limbic allocortex in schizophrenics | Q69518888 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 10850-10854 | |
| P577 | publication date | 1991-12-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia | |
| P478 | volume | 88 |
| Q52051289 | A neural network simulation of hallucinated "voices" and associated speech perception impairments in schizophrenic patients. |
| Q24323990 | A third member of the synapsin gene family |
| Q44061504 | Alterations in MAP2 immunocytochemistry in areas 9 and 32 of schizophrenic prefrontal cortex |
| Q48636668 | Alterations in hippocampal non-phosphorylated MAP2 protein expression in schizophrenia |
| Q48392904 | Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice |
| Q81471371 | Altered prepulse inhibition in mice with dendrite abnormalities of hippocampal neurons |
| Q40794805 | Altered tau and neurofilament proteins in neuro-degenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias |
| Q48698691 | Anterior hippocampus in schizophrenia pathogenesis: molecular evidence from a proteome study |
| Q31864319 | Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex |
| Q35095245 | Assessing declarative memory in schizophrenia using Wisconsin Card Sorting Test stimuli: the Paired Associate Recognition Test |
| Q35844211 | Association of VSNL1 with schizophrenia, frontal cortical function, and biological significance for its gene product as a modulator of cAMP levels and neuronal morphology |
| Q71479819 | Autoradiographic characterization of neurotensin receptors in the entorhinal cortex of schizophrenic patients and control subjects |
| Q34111013 | Cytokine and growth factor involvement in schizophrenia--support for the developmental model |
| Q80752522 | Decline in age-dependent, MK801-induced injury coincides with developmental switch in parvalbumin expression: cingulate and retrosplenial cortex |
| Q34502678 | Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains |
| Q35680429 | Dendritic spine alterations in schizophrenia |
| Q91835017 | Density of small dendritic spines and microtubule-associated-protein-2 immunoreactivity in the primary auditory cortex of subjects with schizophrenia |
| Q35172666 | Disrupted-in-schizophrenia 1 (DISC1) regulates dysbindin function by enhancing its stability |
| Q34731143 | Do mood symptoms subdivide the schizophrenia phenotype? Association of the GMP6A gene with a depression subgroup |
| Q37480047 | Executive function, neural circuitry, and genetic mechanisms in schizophrenia |
| Q34997789 | Functional genomics and psychiatric illness |
| Q48610577 | Further evidence of abnormal cytoarchitecture of the entorhinal cortex in schizophrenia using spatial point pattern analyses |
| Q64934286 | GAD mRNA in Orbital Prefrontal Cortex and Anterior Cingulate Cortex in Alcoholics Compared with Nonpsychiatric Controls: A Negative Postmortem Study. |
| Q34491452 | GSK-3 and the neurodevelopmental hypothesis of schizophrenia |
| Q37618265 | Genetic polymorphisms and their association with brain and behavioural measures in heterogeneous stock mice |
| Q48245172 | Glutamate receptors, microtubule associated proteins and developmental anomaly in schizophrenia: an hypothesis. |
| Q91750140 | Hippocampal subregion abnormalities in schizophrenia: A systematic review of structural and physiological imaging studies |
| Q49037673 | Human fetal hippocampal development: II. The neuronal cytoskeleton |
| Q52188668 | Human olfactory mucosa in schizophrenia. |
| Q48641308 | Immunoblotting patterns of cytoskeletal dendritic protein expression in human neocortex |
| Q38960118 | Increased Stability of Microtubules in Cultured Olfactory Neuroepithelial Cells from Individuals with Schizophrenia |
| Q73524564 | Increased dendritic MAP2 expression in the hippocampus in schizophrenia |
| Q35947887 | Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia |
| Q35904717 | Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia |
| Q48752142 | Low GSK-3 activity in frontal cortex of schizophrenic patients |
| Q45294580 | MAP2 Splicing is Altered in Huntington's Disease. |
| Q92965300 | MAP2 immunoreactivity deficit is conserved across the cerebral cortex within individuals with schizophrenia |
| Q46793814 | Melatonin increases dendritogenesis in the hilus of hippocampal organotypic cultures |
| Q48460574 | Methylazoxymethanol acetate-induced abnormalities in the entorhinal cortex of the rat; parallels with morphological findings in schizophrenia |
| Q38817194 | Microtubule and microtubule associated protein anomalies in psychiatric disease |
| Q42181843 | Microtubule-associated proteins in mesial temporal lobe epilepsy with and without psychiatric comorbidities and their relation with granular cell layer dispersion |
| Q48121449 | Mitogen-activated protein kinases in schizophrenia |
| Q48638020 | NMDA-glutamate receptors regulate phosphorylation of dendritic cytoskeletal proteins in the hippocampus |
| Q35236271 | Neural models of schizophrenia |
| Q35974517 | Neurodevelopment, neuroplasticity, and new genes for schizophrenia |
| Q48588035 | Neuropsychological functioning in elderly patients with schizophrenia and Alzheimer's disease |
| Q36794279 | New genes associated with schizophrenia in neurite formation: a review of cell culture experiments |
| Q34729740 | New model of action for mood stabilizers: phosphoproteome from rat pre-frontal cortex synaptoneurosomal preparations |
| Q40623093 | New perspectives on the clinical neurobiology of treatment response in schizophrenia |
| Q77482059 | New views on the course and treatment of schizophrenia |
| Q42649750 | Novel transcribed sequences neighbouring a translocation breakpoint associated with schizophrenia |
| Q48770354 | Olfactory identification in elderly schizophrenia and Alzheimer's disease |
| Q46769212 | Ontogeny of altered dendritic morphology in the rat prefrontal cortex, hippocampus, and nucleus accumbens following Cesarean delivery and birth anoxia |
| Q44630221 | Post-weaning social isolation of rats leads to a diminution of LTP in the CA1 to subiculum pathway |
| Q39998926 | Potential application as screening and drug designing tools of cytoarchitectural deficiencies present in three animal models of schizophrenia |
| Q28291484 | Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia |
| Q44452840 | Preservation of hippocampal pyramidal cells in paraphrenia |
| Q38399332 | Proteome and pathway effects of chronic haloperidol treatment in mouse hippocampus. |
| Q72347657 | Purification of microtubule associated protein MAP1B from bovine brain: MAP1B binds to microtubules but not to microfilaments |
| Q46180253 | ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins. |
| Q36043343 | SELENBP1 expression in the prefrontal cortex of subjects with schizophrenia |
| Q73874580 | Schizophrenia |
| Q29618819 | Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence |
| Q36478249 | Schizophrenia: an integrative approach to modelling a complex disorder. |
| Q35146132 | Schizophrenia: from phenomenology to neurobiology |
| Q71971020 | Selective degeneration fo Purkinje cells with Lewy body-like inclusions in aged NFHLACZ transgenic mice |
| Q48682281 | Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits |
| Q39838610 | Synapsin III acts downstream of semaphorin 3A/CDK5 signaling to regulate radial migration and orientation of pyramidal neurons in vivo |
| Q38036916 | Targeting synaptic dysfunction in Alzheimer's disease therapy. |
| Q73484909 | The growth-associated protein GAP-43 is increased in the hippocampus and in the gyrus cinguli in schizophrenia |
| Q33979202 | The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications |
| Q41743479 | The neuroanatomy and neurochemistry of schizophrenia |
| Q35579200 | Understanding schizophrenia as a disorder of consciousness: biological correlates and translational implications from quantum theory perspectives |
| Q73155297 | Using a speech perception neural network simulation to explore normal neurodevelopment and hallucinated 'voices' in schizophrenia |
| Q31120582 | Very poor outcome schizophrenia: clinical and neuroimaging aspects |
| Q37203352 | Voxel-based morphometry in schizophrenia: implications for neurodevelopmental connectivity models, cognition and affect |
| Q30610218 | What happens in the brain of schizophrenia patients?: an investigation from the viewpoint of neuropathology |
| Q60800989 | mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders |
Search more.